Beijing In-Cure-Ace Biological Products Research Institute

Beijing In-Cure-Ace Biological Products Research Institute is a Chinese biotechnology company focused on the development of therapeutic vaccines and immunotherapies for chronic viral infections and cancer. The institute is best known for its proprietary In-Cure-Ace platform, which aims to stimulate the immune system to clear persistent infections such as HPV, HBV, and HIV. Their lead programs are focused on treating high-risk HPV infections and preventing the progression to cervical cancer. The company operates primarily in the research and clinical development stages within the Chinese domestic market, leveraging its specialized expertise in viral immunology.